| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $78.6M | -6.1% |
| SG&A Expense | $29.9M | -5.8% |
| Operating Income | -$108.5M | +6.0% |
| Pre-tax Income | -$113.6M | +6.7% |
| Income Tax | $930K | +117.3% |
| Net Income | -$114.5M | +6.3% |
| EPS (Basic) | -$1.31 | +43.3% |
| EPS (Diluted) | -$1.31 | +43.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.9M | -30.0% |
| Current Assets | $51.6M | -27.4% |
| Total Assets | $64.4M | -26.7% |
| Current Liabilities | $12.4M | -28.6% |
| Long-term Debt | $43.6M | -6.3% |
| Total Liabilities | $69.4M | -12.3% |
| Stockholders' Equity | -$5.0M | -157.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$101.2M | -4.7% |
| Capital Expenditures | $622K | -59.1% |
| Investing Cash Flow | -$622K | +58.0% |
| Financing Cash Flow | $81.7M | -16.3% |
| Free Cash Flow | -$101.9M | -3.7% |